AIP
ATNM icon

Ameritas Investment Partners’s Actinium Pharmaceuticals ATNM Stock Holding History

Ameritas Investment Partners’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,148
Closed -$3.46K – 3210
2025
Q1 		$3.46K Hold
2,148
– – ﹤0.01% 3028
2024
Q4 		$2.71K Hold
2,148
– – ﹤0.01% 3089
2024
Q3 		$4.04K Hold
2,148
– – ﹤0.01% 3061
2024
Q2 		$15.9K Hold
2,148
– – ﹤0.01% 2715
2024
Q1 		$16.8K Hold
2,148
– – ﹤0.01% 2628
2023
Q4 		$10.9K Hold
2,148
– – ﹤0.01% 2822
2023
Q3 		$12.7K Hold
2,148
– – ﹤0.01% 2728
2023
Q2 		$15.9K Buy
+2,148
New +$18.3K ﹤0.01% 2679

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Ameritas Investment Partners's ATNM Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Actinium Pharmaceuticals (ATNM) in Q2 2025, closing a stake of 2,148 shares — an estimated $3.46K sold.

Ameritas Investment Partners first reported a position in ATNM in Q2 2023 and held it in 8 quarters. The position peaked at $16.8K in Q1 2024. 63 funds tracked by Wall St. Rank hold ATNM as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Actinium Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,148 Actinium Pharmaceuticals shares in Q2 2025, an estimated $3.46K.
  • Ameritas Investment Partners first reported a position in Actinium Pharmaceuticals in Q2 2023 and held it in 8 quarters.
  • Ameritas Investment Partners's Actinium Pharmaceuticals position peaked at $16.8K in Q1 2024.
  • 63 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.